ClinicalTrials.gov
public full text
Public Domain
Satisfaction and Compliance of Risedronate in PMO
Compare subject satisfaction of once a week dosing of 35 mg Risedronate to once daily dosing of 5 mg Risedronate in postmenopausal osteoporotic women. Secondary objectives are to measure compliance (50 % drug taken), and persistence.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness of Oral Boldo in Women With Overactive Bladder#812771
- Drug Discrimination in Methadone-Maintained Humans Study 2#830463
- Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)#1095663
- Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users#1095427
- Disease-Modifying Treatments for Myasthenia Gravis#889182
Record · ID 907654
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive